Herskowitz Neil — SEC Form 4 filings
SEC reporting owner CIK 1298246. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-05-16 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 270 shares, $284 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 247 shares @ $0.96 ($238) in MUSTANG BIO, INC., filed 2025-12-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | Director | 1 | — | 1 leg · 247 sh · $238 | — |
| AVENUE THERAPEUTICS, INC. (ATXI) | Director | 2 | — | 1 leg · 23 sh · $46 | 1 |
| Checkpoint Therapeutics, Inc. (CKPT) | Director | 3 | — | — | 5 |
| Journey Medical Corp (DERM) | Director | 5 | — | — | 5 |
Form 4 filings — Herskowitz Neil
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-06-26 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2025-12-30 | 4 | MUSTANG BIO, INC. (MBIO) | Sale (S): 247 @ $0.96 | EDGAR |
| 2025-08-07 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2025-07-07 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 7,173 @ $0 | EDGAR |
| 2025-05-30 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 12,195 @ $0 · Code (U): 147,007 | EDGAR |
| 2024-12-17 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 17,638 @ $0 | EDGAR |
| 2024-12-03 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Sale (S): 23 @ $2 | EDGAR |
| 2024-09-25 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-07-10 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 9,728 @ $0 | EDGAR |
| 2024-05-16 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 32,051 @ $0 · Grant/award (A): 50,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1298246 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →